DUBLIN--(http://www.researchandmarkets.com/research/fl3m24/global_drugs_of) has announced the addition of the "Global Drugs of Abuse Testing Market 2011-2015" report to their offering.)--Research and Markets (
“Global Drugs of Abuse Testing Market 2011-2015”
One of the key factors contributing to this market growth is that companies are adopting DOA testing in their workplace policies. The Global DOA Testing market has also been witnessing the trend of the availability of rapid home DOA testing kits. However, the fragmented nature of the market could pose a challenge to the growth of this market.
Key vendors dominating this space include Beckman Coulter Inc., Roche Diagnostic Corp., Siemens Healthcare Diagnostic Inc., and Thermo Fisher Scientific Inc.
Other vendors mentioned in the report are MEDTOX Scientific Inc., Varian Medical Systems Inc., Abbott Laboratories, Agilent Technologies Inc., Alere Inc. Bio-Rad Laboratories Inc., OraSure Technologies Inc., and Ortho Clinical Diagnostic Inc.
Commenting on the report, an analyst from TechNavio's Healthcare team said: ''Vendors in the Global Drugs of Abuse (DOA) Testing market are working on innovations to develop products that can give quick and accurate DOA test results. Previously, DOA tests were performed in laboratories under the supervision of experts. Now, these tests can be done at home with simple home DOA test kits. The rapid home DOA test is based on the same technology, but there is no need to send the sample to a laboratory, and results can be gained within minutes at a point-of-care (POC). Due to the presence of such products a person can perform a DOA test at home, privately. These rapid home DOA test kits are very helpful for parents who might want to test their children for drug abuse. The availability of rapid tests could dramatically increase the number of people taking DOA tests. Thus, the availability of home DOA testing kits will help the Global DOA Testing market to grow.''
For more information visit http://www.researchandmarkets.com/research/fl3m24/global_drugs_of